- IN₹1.09tn
- IN₹994.60bn
- IN₹281.63bn
Indian pharma stocks rise as Nomura flags strong March sales
Brief: Cipla Receives USFDA Approval For First AB-Rated Generic Of Ventolin HFA
Brief: Cipla's Manufacturing Facility In Goa Undergoes US FDA Inspection
Star anise gives chipmakers a recipe for shortages
Brief: Cipla Expands U.S. Respiratory Portfolio With Approval Of Nintedanib Capsules (100Mg & 150Mg) For Idiopathic Pulmonary Fibrosis
UBS initiates Indian pharma coverage amid weight-loss drug opportunity
Brief: Cipla Approved Investment Upto USD 100 Million In Equity Share Capital Of Cipla (EU) Limited
Brief: Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation
Brief: Cipla Says U.S. Unit To Initiate Recall Of Lanreotide Injection
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
South Africa seeks local production of Gilead's HIV prevention drug
Brief: Cipla Enters JV With Kemwell Biopharma For Biologic Products
Brief: Cipla Incorporates Subsidiary Cipla Middle East Company In Kingdom Of Saudi Arabia
Brief: Cipla Announces Launch Of Generic Saxenda For Weight Management Therapy
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
India's Cipla drops as US FDA urges action at key tumour drug supplier's facility
Brief: LIC Raises Stake In Cipla To 9.091% From 7.055% Between Nov And Feb- Filing
Lilly targets India as global export hub amid booming Mounjaro sales, executive says (updated)
Lilly targets India as global export hub amid booming Mounjaro sales, executive says